
ATL Announces New VP of Human Resources
November 2, 2023
Springville, Utah, October 27, 2023—ATL Technology, a dynamic and rapidly expanding company specializing in medical device development and manufacturing, is thrilled to introduce Danelle Goulet as the new Vice President of Human Resources.
Expressing her enthusiasm for her new role, Danelle shared, “I am excited by the challenge of a fast-growing company in the medical device space. The company’s commitment to its customers, investors, and employees is impressive, but ultimately, we are all here for the patients that will benefit from the medical device innovations that ATL drives. That is something very special to be a part of at this time.”
Before joining the ATL Technology family, Danelle served as the Vice President of HR & Facilities for Advanced Input Systems. Danelle also held leadership roles at IBM and Amgen.
ATL Technology CEO, Joe Glover, said. “Danelle’s experience is well aligned to ATL’s growth trajectory, and I am confident that she will be a great addition to our leadership team and help us continue to grow in a way that benefits all stakeholders.”
About ATL Technology: Founded in 1993, ATL is a fast-growing medical device company offering design, development, and manufacturing services. The company focuses on providing its customers with world-class engineering solutions to help them accelerate medical device innovation.
For media inquiries or more information, please contact:
Dianna Fox, Sr. Global Marketing Director
Tel +1 224.430.4690
Email: Dianna.fox@atltechnology.com
www.atltechnology.com
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp















